Naldemedine/oxycodoneOpioid withdrawal syndrome and opioid-induced constipation: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1800卷 / 1期
关键词：
D O I：
10.1007/s40278-020-77587-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 225
相关论文
共 50 条
  • [31] Opioid-Induced Constipation and Acupuncture: A Case Discussion
    Olson, Emily A.
    Metzger, Abbey K.
    Mallory, Molly J.
    Mackey, Regina M.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2021, 62 (04) : 876 - 880
  • [32] Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation
    Kanemasa, Toshiyuki
    Koike, Katsumi
    Arai, Tohko
    Ono, Hiroko
    Horita, Narumi
    Chiba, Hiroki
    Nakamura, Atsushi
    Morioka, Yasuhide
    Kihara, Tsuyoshi
    Hasegawa, Minoru
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31 (05):
  • [33] Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial
    Ozaki, Anna
    Kessoku, Takaomi
    Tanaka, Kosuke
    Yamamoto, Atsushi
    Takahashi, Kota
    Takeda, Yuma
    Kasai, Yuki
    Iwaki, Michihiro
    Kobayashi, Takashi
    Yoshihara, Tsutomu
    Kato, Takayuki
    Suzuki, Akihiro
    Honda, Yasushi
    Ogawa, Yuji
    Fuyuki, Akiko
    Imajo, Kento
    Higurashi, Takuma
    Yoneda, Masato
    Taguri, Masataka
    Ishiki, Hiroto
    Kobayashi, Noritoshi
    Saito, Satoru
    Ichikawa, Yasushi
    Nakajima, Atsushi
    CANCERS, 2022, 14 (09)
  • [34] Factors affecting the effect of naldemedine for opioid-induced constipation: a single-institution, retrospective analysis
    Kanbayashi, Y.
    Amaya, F.
    Ueno, H.
    Tabuchi, Y.
    Ishikawa, T.
    Takayama, K.
    Taguchi, T.
    PHARMAZIE, 2021, 76 (04): : 175 - 178
  • [35] INDIRECT TREATMENT COMPARISONS AND NETWORK META-ANALYSES OF NALDEMEDINE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION
    Beale, R.
    Conway, P.
    Cai, B.
    Krauter, E.
    Langford, B.
    Hall, A.
    Eddowes, L.
    VALUE IN HEALTH, 2019, 22 : S178 - S178
  • [36] Effects of Naldemedine: A Peripherally Acting Mu-Opioid Receptor Antagonist in Rat Models of Opioid-Induced Constipation
    Kanemasa, Toshiyuki
    Koike, Katsami
    Arai, Tohko
    Horita, Narumi
    Chiba, Hiroki
    Kihara, Tsuyoshi
    Hasegawa, Minora
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S578 - S578
  • [37] Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status
    Fujita, Yukiyoshi
    Imai, Hisao
    Hiruta, Eriko
    Masuno, Takashi
    Yamazaki, Shigeki
    Tanaka, Hajime
    Kamiya, Teruhiko
    Sandoh, Mitsuru
    Takei, Satoshi
    Arai, Kazuya
    Nishiba, Hiromi
    Mogi, Junnosuke
    Koizuka, Shiro
    Saito, Taeko
    Obayashi, Kyoko
    Kaira, Kyoichi
    Minato, Koichi
    JOURNAL OF PALLIATIVE MEDICINE, 2023, 26 (04) : 548 - 553
  • [38] Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer Reply
    Katakami, Nobuyuki
    Yokota, Takaaki
    Tada, Yukio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (10) : 1050 - +
  • [39] Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report
    Blackney, Kevin A.
    Kamdar, Nirav V.
    Liu, Chang Amber
    Edwards, David A.
    A & A PRACTICE, 2019, 12 (02): : 44 - 46
  • [40] Fentanyl/Hydrocodone/OxycodoneOpioid use disorder and opioid withdrawal symptoms: case report
    Reactions Weekly, 2024, 2037 (1) : 179 - 179
12345